Pancreatic Cancer
What's New
Last Posted: Jun 27, 2024
- Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer.
Claudia Rosso et al. J Natl Compr Canc Netw 2024 1-7 - Noninvasive prediction of lymph node metastasis in pancreatic cancer using an ultrasound-based clinicoradiomics machine learning model.
Dong-Yue Wen et al. Biomed Eng Online 2024 23(1) 56 - The role of germline BRCA1 & BRCA2 mutations in familial pancreatic cancer: A systematic review and meta-analysis.
Edward Kurnia Setiawan Limijadi et al. PLoS One 2024 19(5) e0299276 - Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer.
Louise Wang et al. Fam Cancer 2024 - The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer.
Julie Earl et al. Fam Cancer 2024 - Expanding access to genetic testing for pancreatic cancer.
Nicolette Juliana Rodriguez et al. Fam Cancer 2024 - Development and Application of a Novel Machine Learning Model Predicting Pancreatic Cancer-Specific Mortality.
Yongji Sun et al. Cureus 2024 16(3) e57161 - Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.
Florian Rumpf et al. J Urol 2024 101097JU0000000000003927 - Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
Tarun Mehra et al. PLoS One 2024 19(4) e0301271 - Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
Zhiyuan Wu et al. BMC Cancer 2024 24(1) 411 - Lynch Syndrome Ups Risk for Colorectal, Other Cancers
E Herlache, Cancer Care, March 2024 - The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals.
Livia Archibugi et al. Fam Cancer 2024 - Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer.
Qingyang Xiao et al. J Natl Cancer Inst 2024 - Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic cancer.
Neeharika Agnihotri et al. Pancreatology 2024 - Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma
L Jiang et al, Nature Medicine, January 29, 2024 - From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer.
Satvik Tripathi et al. Diagnostics (Basel) 2024 14(2) - The Utility of Artificial Intelligence in the Diagnosis and Management of Pancreatic Cancer.
Vikash Kumar et al. Cureus 2023 15(11) e49560 - Air quality and cancer risk in the All of Us Research Program.
Andrew Craver et al. Cancer Causes Control 2023 - TransformEHR: transformer-based encoder-decoder generative model to enhance prediction of disease outcomes using electronic health records.
Zhichao Yang et al. Nat Commun 2023 14(1) 7857 - Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review.
Daniele Campa et al. Mutagenesis 2023
More
About Cancer PHGKB
Cancer PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to cancer...more
Content Summary
Common Type
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: